Acknowledgement
This work was supported in part by the National Natural Science Foundation of China (Grant no: 82272005), Shanghai Municipal Health Commission (Grant no: SHSLCZDZK 03502 and 19441903200) and Science and Technology Commission of Shanghai Municipality (Grant no: 19DZ2251100 and 2019LJ21).
References
- Xu Y, Evans M, Soro M, Barany P, Carrero JJ. Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease. Clin Kidney J 2021;14:2213-2220
- Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007;117:4003-4008
- Rodriguez M, Nemeth E, Martin D. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 2005;288:F253-F264
- Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005;35:266-276
- Tang JA, Friedman J, Hwang MS, Salapatas AM, Bonzelaar LB, Friedman M. Parathyroidectomy for tertiary hyperparathyroidism: a systematic review. Am J Otolaryngol 2017;38:630-635
- Sutton W, Chen X, Patel P, Karzai S, Prescott JD, Segev DL, et al. Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients. Surgery 2022;171:69-76
- Hsu CY, Chen LR, Chen KH. Osteoporosis in patients with chronic kidney diseases: a systemic review. Int J Mol Sci 2020;21:6846
- Lemoine S, Figueres L, Bacchetta J, Frey S, Dubourg L. Calcium homeostasis and hyperparathyroidism: nephrologic and endocrinologic points of view. Ann Endocrinol (Paris) 2022;83:237-243
- Ozdemir FN, Afsar B, Akgul A, Usluog˘ullari C, Akcay A, Haberal M. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 2006;38:480-482
- Egbuna OI, Taylor JG, Bushinsky DA, Zand MS. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 2007;21:558-566
- Levy AR, Xing S, Brunelli SM, Cooper K, Finkelstein FO, Germain MJ, et al. Symptoms of secondary hyperparathyroidism in patients receiving maintenance hemodialysis: a prospective cohort study. Am J Kidney Dis 2020;75:373-383
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009;113:S1-S130
- Dream S, Kuo LE, Kuo JH, Sprague SM, Nwariaku FE, Wolf M, et al. The American Association of endocrine surgeons guidelines for the definitive surgical management of secondary and tertiary renal hyperparathyroidism. Ann Surg 2022;276:e141-e176
- Chen Z, Cheng L, Zhang W, He W. Ultrasound-guided thermal ablation for hyperparathyroidism: current status and prospects. Int J Hyperthermia 2022;39:466-474
- Hu Z, Han E, Chen W, Chen J, Chen W, Guo R. Feasibility and safety of ultrasound-guided percutaneous microwave ablation for tertiary hyperparathyroidism. Int J Hyperthermia 2019;36:1129-1136
- Li X, An C, Yu M, Peng L. US-guided microwave ablation for secondary hyperparathyroidism in patients after renal transplantation: a pilot study. Int J Hyperthermia 2019;36:322-327
- Douthat WG, Orozco SE, Maino P, Cardozo G, de Arteaga J, de la Fuente J, et al. Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism. Transpl Int 2007;20:1031-1035
- Tominaga Y. Management of renal hyperparathyroidism. Biomed Pharmacother 2000;54(Suppl 1):25s-31s
- Choi HR, Aboueisha MA, Attia AS, Omar M, ELnahla A, Toraih EA, et al. Outcomes of subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for tertiary hyperparathyroidism: multi-institutional study. Ann Surg 2021;274:674-679
- Peng C, Zhang Z, Liu J, Chen H, Tu X, Hu R, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck 2017;39:564-571
- Mauri G, Pacella CM, Papini E, Solbiati L, Goldberg SN, Ahmed M, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid 2019;29:611-618
- Lin YS, Hsueh C, Wu HY, Yu MC, Chao TC. Incidental parathyroidectomy during thyroidectomy increases the risk of postoperative hypocalcemia. Laryngoscope 2017;127:2194-2200
- Zhou HY, He JC, McHenry CR. Inadvertent parathyroidectomy: incidence, risk factors, and outcomes. J Surg Res 2016;205:70-75
- Moreno P, Coloma A, Torregrosa JV, Montero N, Francos J, Codina S, et al. Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism. Clin Transplant 2020;34:e13988
- Rivelli GG, Lima ML, Mazzali M. Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy. J Bras Nefrol 2020;42:315-322
- Ramonell KM, Lindeman B, Chen H, Fazendin J. Parathyroidectomy for normocalcemic tertiary hyperparathyroidism: a 19-year experience. J Surg Res 2022;276:362-368
- Kovacs DA, Fedor R, Asztalos L, Andrasi M, Szabo RP, Kanyari Z, et al. Surgical treatment of hyperparathyroidism after kidney transplant. Transplant Proc 2019;51:1244-1247
- Patecki M, Scheffner I, Haller H, Gwinner W. Long-term renal graft outcome after parathyroidectomy - a retrospective single centre study. BMC Nephrol 2020;21:53
- Li D, Wang G, Chen X, Guo W, Huang H, Diao Z, et al. Long-term effect of microwave ablation on patients undergoing hemodialysis for moderate secondary hyperparathyroidism: a retrospective cohort study. J Ultrasound Med 2021;40:2497-2505
- Diao Z, Qian L, Teng C, Zhang N, Liang J, Kong L, et al. Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study. Int J Hyperthermia 2021;38:213-219
- Qin X, Wang B, Li B, Lin C, Liu X, Xie X. Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism. Ren Fail 2021;43:445-451
- Wei Y, Peng LL, Zhao ZL, Li Y, Yu MA. Risk factors of severe hypocalcemia after us-guided percutaneous microwave ablation of the parathyroid gland in patients with secondary hyperparathyroidism. J Bone Miner Res 2020;35:691-697
- Rayes N, Seehofer D, Schindler R, Reinke P, Kahl A, Ulrich F, et al. Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg 2008;143:756-761; discussion 761
- Faye M, Keita N, Lemrabott AT, Algouzmari I, Faye M, Mbengue M, et al. Surgical management of secondary hyperparathyroidism in dialysis patients in Senegal. Saudi J Kidney Dis Transpl 2021;32:1424-1430
- Zhao J, Qian L, Teng C, Yu M, Liu F, Liu Y, et al. A short-term non-randomized controlled study of ultrasound-guided microwave ablation and parathyroidectomy for secondary hyperparathyroidism. Int J Hyperthermia 2021;38:1558-1565
- Meng C, Martins P, Frazao J, Pestana M. Parathyroidectomy in persistent post-transplantation hyperparathyroidism-single-center experience. Transplant Proc 2017;49:795-798